Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
[ad_1]
Novo Nordisk and Eli Lilly have given positive supply updates, aiming to reassure investors that they can continue to capitalize on the success of their drugs.
[ad_2]
Source link